Reaksi Drug Safety News 2017 - Issue 6/2017 Print User Rating: 1 / 5 Please Rate Vote 1 Vote 2 Vote 3 Vote 4 Vote 5 Reaksi Drug Safety News 2017, Issue 6/2017 Ketamine: Risk of Severe Liver Damage with Repeated and/or Prolonged Use at High Doses Recombinant Human Erythropoietins: Risk of Severe Cutaneous Adverse Reactions (SCARs) DOWNLOAD PDF Reaksi Archive